Augmentin '500' and Celebrex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 8 people who take Augmentin '500' and Celebrex. Common interactions include anxiety among females.

The phase IV clinical study analyzes what interactions people who take Augmentin '500' and Celebrex have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 28, 2023

8 people who take Augmentin '500' and Celebrex together, and have interactions are studied.


What is Augmentin '500'?

Augmentin '500' has active ingredients of amoxicillin; clavulanate potassium. It is used in sinusitis. Currently, eHealthMe is studying from 508 Augmentin '500' users.

What is Celebrex?

Celebrex has active ingredients of celecoxib. It is used in arthritis. Currently, eHealthMe is studying from 146,838 Celebrex users.

Number of Augmentin '500' and Celebrex reports submitted per year:

Augmentin '500' and Celebrex drug interactions.

Common Augmentin '500' and Celebrex drug interactions by gender *:

female:

  1. Anxiety
  2. Depression
  3. Anhedonia
  4. Deep vein thrombosis
  5. Dyspepsia
  6. Fall
  7. Haemorrhoids
  8. Injury
  9. Nasal congestion
  10. Nasal septum deviation

male:

n/a



Common Augmentin '500' and Celebrex drug interactions by age *:

0-1:

  1. Anxiety
  2. Back pain
  3. Bone density decreased
  4. Breast cancer
  5. Calcium deficiency
  6. Chest pain
  7. Depression
  8. Diabetes mellitus
  9. Gastric haemorrhage
  10. Intestinal obstruction

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. General physical health deterioration
  2. Injury
  3. Pulmonary embolism
  4. Anhedonia
  5. Anxiety
  6. Deep vein thrombosis
  7. Emotional distress

50-59:

  1. Diarrhoea
  2. Dyspnoea
  3. Haematuria
  4. Headache
  5. Impaired healing
  6. Malaise
  7. Micturition urgency
  8. Myalgia
  9. Nephrolithiasis
  10. Nocturia

60+:

  1. Blood pressure increased
  2. Nasal congestion
  3. Oedema peripheral
  4. Oropharyngeal pain

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '500' and Celebrex?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Drug side effects by duration, gender and age:

Browse interactions between Augmentin '500' and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Celebrex drug interactions:

Browse interactions between Celebrex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and celecoxib (the active ingredients of Augmentin '500' and Celebrex, respectively), and Augmentin '500' and Celebrex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Augmentin '500' and Celebrex.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: